69 related articles for article (PubMed ID: 3470542)
21. Non-Hodgkin's lymphoma in women with breast cancer.
Wiernik PH; Hu X; Ratech H; Fineberg S; Marino P; Schleider MA; Etkind P; Walewski JA
Cancer J; 2000; 6(5):336-42. PubMed ID: 11079174
[TBL] [Abstract][Full Text] [Related]
22. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital.
Sukpanichnant S; Sonakul D; Piankijagum A; Wanachiwanawin W; Veerakul G; Mahasandana C; Tanphaichitr VS; Suvatte V
Cancer; 1998 Sep; 83(6):1197-204. PubMed ID: 9740086
[TBL] [Abstract][Full Text] [Related]
23. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
24. [Reproducibility of a non-Hodgkin's lymphoma classification].
Apaja-Sarkkinen M; Alavaikko M
Vopr Onkol; 1987; 33(1):51-7. PubMed ID: 3811310
[TBL] [Abstract][Full Text] [Related]
25. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation.
Percy C; O'Conor G; Ries LG; Jaffe ES
Cancer; 1984 Oct; 54(7):1435-8. PubMed ID: 6467164
[TBL] [Abstract][Full Text] [Related]
27. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
28. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
29. [Non-Hodgkin's lymphoma: biologic classification, diagnosis and treatment].
Jiménez-Zepeda VH; Jiménez-Zepeda RJ
Gac Med Mex; 1998; 134(4):443-63. PubMed ID: 9789388
[TBL] [Abstract][Full Text] [Related]
30. Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases.
Woodruff RD
Arch Pathol Lab Med; 1981 Nov; 105(11):573-6. PubMed ID: 7027993
[TBL] [Abstract][Full Text] [Related]
31. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
[TBL] [Abstract][Full Text] [Related]
32. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women.
Zhang Y; Holford TR; Leaderer B; Boyle P; Zahm SH; Zhang B; Zou K; Morton LM; Owens PH; Flynn S; Tallini G; Zheng T
Am J Epidemiol; 2004 Oct; 160(8):766-73. PubMed ID: 15466499
[TBL] [Abstract][Full Text] [Related]
33. WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies.
Turner JJ; Hughes AM; Kricker A; Milliken S; Grulich A; Kaldor J; Armstrong B
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2213-9. PubMed ID: 16172234
[TBL] [Abstract][Full Text] [Related]
34. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow and peripheral blood changes in non-Hodgkin's lymphoma.
Lim EJ; Peh SC
Singapore Med J; 2000 Jun; 41(6):279-85. PubMed ID: 11109344
[TBL] [Abstract][Full Text] [Related]
36. Malignant lymphoma in western Ethiopia.
Getachew A
East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
[TBL] [Abstract][Full Text] [Related]
37. Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas.
Ezdinli EZ; Costello W; Wasser LP; Lenhard RE; Berard CW; Hartsock R; Bennett JM; Carbone PP
Cancer; 1979 Feb; 43(2):544-50. PubMed ID: 369677
[TBL] [Abstract][Full Text] [Related]
38. Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas. An analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma.
Nanba K; Yamamoto H; Kamada N; Kikuchi M; Suchi T; Frizzera G; Berard CW; Shimamura K; Kaneko Y; Sakurai M
Cancer; 1987 Apr; 59(8):1463-9. PubMed ID: 3815313
[TBL] [Abstract][Full Text] [Related]
39. Observer variation in the pathologic diagnosis of malignant lymphoma in Canada.
Burns BF; Comrie W; Willan AR; McCaughey WT
Cancer; 1988 Jul; 62(2):314-8. PubMed ID: 3383132
[TBL] [Abstract][Full Text] [Related]
40. Are epidemiological data on lymphoma incidence comparable? Results from an application of the coding recommendations of WHO, InterLymph, ENCR and SEER to a cancer registry dataset.
Adzersen KH; Friedrich S; Becker N
J Cancer Res Clin Oncol; 2016 Jan; 142(1):167-75. PubMed ID: 26206482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
